Blueshift Ideas Says Thoratec Corporation Will Dominate

Blueshift Ideas is out with a series of tweets on Thoratec Corporation THOR, saying the company will "dominate" in the space for the next six to twelve months. The company's competitor, HeartWare International Inc HTWR, has a device that is expected to compete with Thoratec for the next generation device. Blueshift says that Thoratec's first to market position and reputation in the medical community will help it in the coming months. According to Blueshift, "Sources universally expect use of LVAD's to grow, with four expecting the market to double to triple worldwide during the next five years."